ARTICLE | Company News
SIRS-Lab, Pfizer deal
December 6, 2010 8:00 AM UTC
SIRS-Lab and Pfizer partnered to develop molecular diagnostic tests for sepsis. The companies will initially focus on severe fungal blood-stream infections and examine the effect of molecular test-bas...